Skip to main content
Top
Published in: World Journal of Surgery 2/2017

01-02-2017 | Original Scientific Report

Risk Factors for Anastomotic Stricture Post-esophagectomy with a Standardized Sutured Anastomosis

Authors: Zuhair Ahmed, Jessie A. Elliott, Sinead King, Claire L. Donohoe, Narayanasamy Ravi, John V. Reynolds

Published in: World Journal of Surgery | Issue 2/2017

Login to get access

Abstract

Background

Benign anastomotic strictures occur frequently after esophagectomy, and impact on postoperative recovery, nutritional status, and quality of life. This large cohort study explored the incidence of stricture after transthoracic (2- and 3-stage) and transhiatal resections with uniform single-layer sutured anastomotic technique, and aimed to identify independent risk factors.

Methods

Patients undergoing esophagectomy with gastric conduit reconstruction between February 2001 and October 2014 were studied prospectively. Symptomatic anastomotic stricture was defined as dysphagia requiring endoscopic dilatation, and refractory strictures as those requiring >5 dilatations. Multivariable logistic regression was performed to determine factors independently associated with stricture development.

Results

Five-hundred and twenty-four patients, 77 % with adenocarcinoma, underwent esophagectomy [2-stage, n = 328 (62.6 %); 3-stage, n = 129 (23.3 %); transhiatal, n = 74 (14.1 %)], with an overall inhospital mortality rate of 2.7 %. 58.5 % of patients received neoadjuvant therapy [chemotherapy only, n = 119 (22.7 %); chemoradiation, n = 188 (35.9 %)]. Anastomotic stricture developed in 125 patients (24.5 %), was refractory in 20 (3.9 %) and required a median of 2 dilatations (range 1–18). On multivariable analysis, ASA grade (P < 0.05), cervical anastomosis (P < 0.001), and a significant postoperative cardiac event (P < 0.05) were independently associated with stricture risk. Refractory strictures were independently associated with anastomotic leak (P = 0.01) and transhiatal resections (P < 0.001).

Conclusion

Benign anastomotic strictures are common, particularly with cervical reconstruction, and after transhiatal resection. Refractory strictures are rare. Where fitness and oncologic equivalence apply, a thoracic anastomosis provides significant advantages compared with a cervical anastomosis in terms of anastomotic stricture risk.
Appendix
Available only for authorised users
Literature
1.
go back to reference Reynolds JV, Donohoe CL, McGillycuddy E, Ravi N, O’Toole D, O’Byrne K, Hollywood D (2012) Evolving progress in oncologic and operative outcomes for esophageal and junctional cancer: lessons from the experience of a high-volume center. J Thorac Cardiovasc Surg 143(5):1130–1137.e1CrossRefPubMed Reynolds JV, Donohoe CL, McGillycuddy E, Ravi N, O’Toole D, O’Byrne K, Hollywood D (2012) Evolving progress in oncologic and operative outcomes for esophageal and junctional cancer: lessons from the experience of a high-volume center. J Thorac Cardiovasc Surg 143(5):1130–1137.e1CrossRefPubMed
2.
go back to reference van Hagen P, Hulshof MC, van Lanschot JJ, Steyerberg EW, van Berge Henegouwen MI, Wijnhoven BP, Richel DJ, Nieuwenhuijzen GA, Hospers GA, Bonenkamp JJ, Cuesta MA, Blaisse RJ, Busch OR, ten Kate FJ, Creemers GJ, Punt CJ, Plukker JT, Verheul HM, Spillenaar Bilgen EJ, van Dekken H, van der Sangen MJ, Rozema T, Biermann K, Beukema JC, Piet AH, van Rij CM, Reinders JG, Tilanus HW, van der Gaast A (2012) Preoperative chemoradiotherapy for esophageal or junctional cancer. N Engl J Med 366(22):2074–2084CrossRefPubMed van Hagen P, Hulshof MC, van Lanschot JJ, Steyerberg EW, van Berge Henegouwen MI, Wijnhoven BP, Richel DJ, Nieuwenhuijzen GA, Hospers GA, Bonenkamp JJ, Cuesta MA, Blaisse RJ, Busch OR, ten Kate FJ, Creemers GJ, Punt CJ, Plukker JT, Verheul HM, Spillenaar Bilgen EJ, van Dekken H, van der Sangen MJ, Rozema T, Biermann K, Beukema JC, Piet AH, van Rij CM, Reinders JG, Tilanus HW, van der Gaast A (2012) Preoperative chemoradiotherapy for esophageal or junctional cancer. N Engl J Med 366(22):2074–2084CrossRefPubMed
3.
go back to reference Orringer MB, Marshall B, Chang AC, Lee J, Pickens A, Lau CL (2007) Two thousand transhiatal esophagectomies: changing trends, lessons learned. Ann Surg 246(3):363–374CrossRefPubMedPubMedCentral Orringer MB, Marshall B, Chang AC, Lee J, Pickens A, Lau CL (2007) Two thousand transhiatal esophagectomies: changing trends, lessons learned. Ann Surg 246(3):363–374CrossRefPubMedPubMedCentral
4.
go back to reference Brusselaers N, Mattsson F, Lagergren J (2014) Hospital and surgeon volume in relation to long-term survival after esophagectomy: systematic review and meta-analysis. Gut 63(9):1393–1400CrossRefPubMed Brusselaers N, Mattsson F, Lagergren J (2014) Hospital and surgeon volume in relation to long-term survival after esophagectomy: systematic review and meta-analysis. Gut 63(9):1393–1400CrossRefPubMed
5.
go back to reference Klevebro F, Alexandersson von Dobeln G, Wang N, Johnsen G, Jacobsen AB, Friesland S, Hatlevoll I, Glenjen NI, Lind P, Tsai JA, Lundell L, Nilsson M (2016) A randomized clinical trial of neoadjuvant chemotherapy versus neoadjuvant chemoradiotherapy for cancer of the esophagus or gastro-esophageal junction. Ann Oncol 27(4):660–667. doi:10.1093/annonc/mdw010 CrossRefPubMed Klevebro F, Alexandersson von Dobeln G, Wang N, Johnsen G, Jacobsen AB, Friesland S, Hatlevoll I, Glenjen NI, Lind P, Tsai JA, Lundell L, Nilsson M (2016) A randomized clinical trial of neoadjuvant chemotherapy versus neoadjuvant chemoradiotherapy for cancer of the esophagus or gastro-esophageal junction. Ann Oncol 27(4):660–667. doi:10.​1093/​annonc/​mdw010 CrossRefPubMed
6.
go back to reference Klevebro F, Johnsen G, Johnson E, Viste A, Myrnas T, Szabo E, Jacobsen AB, Friesland S, Tsai JA, Persson S, Lindblad M, Lundell L, Nilsson M (2015) Morbidity and mortality after surgery for cancer of the esophagus and gastro-esophageal junction: a randomized clinical trial of neoadjuvant chemotherapy vs. neoadjuvant chemoradiation. Eur J Surg Oncol 41(7):920–926CrossRefPubMed Klevebro F, Johnsen G, Johnson E, Viste A, Myrnas T, Szabo E, Jacobsen AB, Friesland S, Tsai JA, Persson S, Lindblad M, Lundell L, Nilsson M (2015) Morbidity and mortality after surgery for cancer of the esophagus and gastro-esophageal junction: a randomized clinical trial of neoadjuvant chemotherapy vs. neoadjuvant chemoradiation. Eur J Surg Oncol 41(7):920–926CrossRefPubMed
7.
go back to reference Markar SR, Karthikesalingam A, Low DE (2015) Enhanced recovery pathways lead to an improvement in postoperative outcomes following esophagectomy: systematic review and pooled analysis. Dis Esophagus 28(5):468–475CrossRefPubMed Markar SR, Karthikesalingam A, Low DE (2015) Enhanced recovery pathways lead to an improvement in postoperative outcomes following esophagectomy: systematic review and pooled analysis. Dis Esophagus 28(5):468–475CrossRefPubMed
8.
go back to reference Preston SR, Markar SR, Baker CR, Soon Y, Singh S, Low DE (2013) Impact of a multidisciplinary standardized clinical pathway on perioperative outcomes in patients with esophageal cancer. Br J Surg 100(1):105–112CrossRefPubMed Preston SR, Markar SR, Baker CR, Soon Y, Singh S, Low DE (2013) Impact of a multidisciplinary standardized clinical pathway on perioperative outcomes in patients with esophageal cancer. Br J Surg 100(1):105–112CrossRefPubMed
9.
go back to reference Lagergren P, Avery KN, Hughes R, Barham CP, Alderson D, Falk SJ, Blazeby JM (2007) Health-related quality of life among patients cured by surgery for esophageal cancer. Cancer 110(3):686–693CrossRefPubMed Lagergren P, Avery KN, Hughes R, Barham CP, Alderson D, Falk SJ, Blazeby JM (2007) Health-related quality of life among patients cured by surgery for esophageal cancer. Cancer 110(3):686–693CrossRefPubMed
10.
go back to reference Petrin G, Ruol A, Battaglia G, Buin F, Merigliano S, Constantini M, Pavei P, Cagol M, Scappin S, Ancona E (2000) Anastomotic stenoses occurring after circular stapling in esophageal cancer surgery. Surg Endosc 14(7):670–674CrossRefPubMed Petrin G, Ruol A, Battaglia G, Buin F, Merigliano S, Constantini M, Pavei P, Cagol M, Scappin S, Ancona E (2000) Anastomotic stenoses occurring after circular stapling in esophageal cancer surgery. Surg Endosc 14(7):670–674CrossRefPubMed
11.
12.
go back to reference Martin L, Jia C, Rouvelas I, Lagergren P (2008) Risk factors for malnutrition after esophageal and cardia cancer surgery. Br J Surg 95(11):1362–1368CrossRefPubMed Martin L, Jia C, Rouvelas I, Lagergren P (2008) Risk factors for malnutrition after esophageal and cardia cancer surgery. Br J Surg 95(11):1362–1368CrossRefPubMed
13.
go back to reference Davis SJ, Zhao L, Chang AC, Orringer MB (2011) Refractory cervical esophagogastric anastomotic strictures: management and outcomes. J Thorac Cardiovasc Surg 141(2):444–448CrossRefPubMed Davis SJ, Zhao L, Chang AC, Orringer MB (2011) Refractory cervical esophagogastric anastomotic strictures: management and outcomes. J Thorac Cardiovasc Surg 141(2):444–448CrossRefPubMed
14.
go back to reference Honkoop P, Siersema PD, Tilanus HW, Stassen LP, Hop WC, van Blankenstein M (1996) Benign anastomotic strictures after transhiatal esophagectomy and cervical esophagogastrostomy: risk factors and management. J Thorac Cardiovasc Surg 111(6):1141–1146 (discussion 1147–1148) CrossRefPubMed Honkoop P, Siersema PD, Tilanus HW, Stassen LP, Hop WC, van Blankenstein M (1996) Benign anastomotic strictures after transhiatal esophagectomy and cervical esophagogastrostomy: risk factors and management. J Thorac Cardiovasc Surg 111(6):1141–1146 (discussion 1147–1148) CrossRefPubMed
15.
go back to reference van Heijl M, Gooszen JA, Fockens P, Busch OR, van Lanschot JJ, van Berge Henegouwen MI (2010) Risk factors for development of benign cervical strictures after esophagectomy. Ann Surg 251(6):1064–1069CrossRefPubMed van Heijl M, Gooszen JA, Fockens P, Busch OR, van Lanschot JJ, van Berge Henegouwen MI (2010) Risk factors for development of benign cervical strictures after esophagectomy. Ann Surg 251(6):1064–1069CrossRefPubMed
16.
go back to reference Dewar L, Gelfand G, Finley RJ, Evans K, Inculet R, Nelems B (1992) Factors affecting cervical anastomotic leak and stricture formation following esophagogastrectomy and gastric tube interposition. Am J Surg 163(5):484–489CrossRefPubMed Dewar L, Gelfand G, Finley RJ, Evans K, Inculet R, Nelems B (1992) Factors affecting cervical anastomotic leak and stricture formation following esophagogastrectomy and gastric tube interposition. Am J Surg 163(5):484–489CrossRefPubMed
17.
go back to reference Briel JW, Tamhankar AP, Hagen JA, DeMeester SR, Johansson J, Choustoulakis E, Peters JH, Bremner CG, DeMeester TR (2004) Prevalence and risk factors for ischemia, leak, and stricture of esophageal anastomosis: gastric pull-up versus colon interposition. J Am Coll Surg 198(4):536–541 (discussion 541–532) CrossRefPubMed Briel JW, Tamhankar AP, Hagen JA, DeMeester SR, Johansson J, Choustoulakis E, Peters JH, Bremner CG, DeMeester TR (2004) Prevalence and risk factors for ischemia, leak, and stricture of esophageal anastomosis: gastric pull-up versus colon interposition. J Am Coll Surg 198(4):536–541 (discussion 541–532) CrossRefPubMed
19.
go back to reference Walsh TN, Noonan N, Hollywood D, Kelly A, Keeling N, Hennessy TP (1996) A comparison of multimodal therapy and surgery for esophageal adenocarcinoma. N Engl J Med 335(7):462–467CrossRefPubMed Walsh TN, Noonan N, Hollywood D, Kelly A, Keeling N, Hennessy TP (1996) A comparison of multimodal therapy and surgery for esophageal adenocarcinoma. N Engl J Med 335(7):462–467CrossRefPubMed
20.
go back to reference Cunningham D, Allum WH, Stenning SP, Thompson JN, Van de Velde CJ, Nicolson M, Scarffe JH, Lofts FJ, Falk SJ, Iveson TJ, Smith DB, Langley RE, Verma M, Weeden S, Chua YJ, Participants MT (2006) Perioperative chemotherapy versus surgery alone for resectable gastresophageal cancer. N Engl J Med 355(1):11–20CrossRefPubMed Cunningham D, Allum WH, Stenning SP, Thompson JN, Van de Velde CJ, Nicolson M, Scarffe JH, Lofts FJ, Falk SJ, Iveson TJ, Smith DB, Langley RE, Verma M, Weeden S, Chua YJ, Participants MT (2006) Perioperative chemotherapy versus surgery alone for resectable gastresophageal cancer. N Engl J Med 355(1):11–20CrossRefPubMed
21.
go back to reference Keegan N, Keane F, Cuffe S, Cunningham M, Ravi N, Lee G, Kennedy M, Grogan W, O’Neill B, Power D, Leonard G, Keane M, Small C, Parker I, Moulton B, O’Reilly S, Reynolds J, Group I (2014) ICORG 10-14: Neo-AEGIS: a randomized clinical trial of neoadjuvant and adjuvant chemotherapy (modified MAGIC regimen) versus neoadjuvant chemoradiation (CROSS protocol) in adenocarcinoma of the esophagus and esophagogastric junction. J Clin Oncol 32(5s):TPS4145 Keegan N, Keane F, Cuffe S, Cunningham M, Ravi N, Lee G, Kennedy M, Grogan W, O’Neill B, Power D, Leonard G, Keane M, Small C, Parker I, Moulton B, O’Reilly S, Reynolds J, Group I (2014) ICORG 10-14: Neo-AEGIS: a randomized clinical trial of neoadjuvant and adjuvant chemotherapy (modified MAGIC regimen) versus neoadjuvant chemoradiation (CROSS protocol) in adenocarcinoma of the esophagus and esophagogastric junction. J Clin Oncol 32(5s):TPS4145
22.
go back to reference Reynolds JV, Muldoon C, Hollywood D, Ravi N, Rowley S, O’Byrne K, Kennedy J, Murphy TJ (2007) Long-term outcomes following neoadjuvant chemoradiotherapy for esophageal cancer. Ann Surg 245(5):707–716CrossRefPubMedPubMedCentral Reynolds JV, Muldoon C, Hollywood D, Ravi N, Rowley S, O’Byrne K, Kennedy J, Murphy TJ (2007) Long-term outcomes following neoadjuvant chemoradiotherapy for esophageal cancer. Ann Surg 245(5):707–716CrossRefPubMedPubMedCentral
23.
go back to reference Sharma P, Kozarek R (2009) Role of esophageal stents in benign and malignant diseases. Am J Gastroenterol 105(2):258–273CrossRefPubMed Sharma P, Kozarek R (2009) Role of esophageal stents in benign and malignant diseases. Am J Gastroenterol 105(2):258–273CrossRefPubMed
24.
go back to reference Ripley RT, Sarkaria IS, Grosser R, Sima CS, Bains MS, Jones DR, Adusumilli PS, Huang J, Finley DJ, Rusch VW, Rizk NP (2016) Pretreatment dysphagia in esophageal cancer patients may eliminate the need for staging by endoscopic ultrasonography. Ann Thorac Surg 101(1):226–230CrossRefPubMed Ripley RT, Sarkaria IS, Grosser R, Sima CS, Bains MS, Jones DR, Adusumilli PS, Huang J, Finley DJ, Rusch VW, Rizk NP (2016) Pretreatment dysphagia in esophageal cancer patients may eliminate the need for staging by endoscopic ultrasonography. Ann Thorac Surg 101(1):226–230CrossRefPubMed
25.
go back to reference Mellow MH, Pinkas H (1985) Endoscopic laser therapy for malignancies affecting the esophagus and gastresophageal junction. Analysis of technical and functional efficacy. Arch Intern Med 145(8):1443–1446CrossRefPubMed Mellow MH, Pinkas H (1985) Endoscopic laser therapy for malignancies affecting the esophagus and gastresophageal junction. Analysis of technical and functional efficacy. Arch Intern Med 145(8):1443–1446CrossRefPubMed
26.
go back to reference Thygesen K, Alpert JS, Jaffe AS, Simoons ML, Chaitman BR, White HD, Thygesen K, Alpert JS, White HD, Jaffe AS, Katus HA, Apple FS, Lindahl B, Morrow DA, Chaitman BA, Clemmensen PM, Johanson P, Hod H, Underwood R, Bax JJ, Bonow RO, Pinto F, Gibbons RJ, Fox KA, Atar D, Newby LK, Galvani M, Hamm CW, Uretsky BF, Steg PG, Wijns W, Bassand JP, Menasche P, Ravkilde J, Ohman EM, Antman EM, Wallentin LC, Armstrong PW, Simoons ML, Januzzi JL, Nieminen MS, Gheorghiade M, Filippatos G, Luepker RV, Fortmann SP, Rosamond WD, Levy D, Wood D, Smith SC, Hu D, Lopez-Sendon JL, Robertson RM, Weaver D, Tendera M, Bove AA, Parkhomenko AN, Vasilieva EJ, Mendis S (2012) Third universal definition of myocardial infarction. Eur Heart J 33(20):2551–2567CrossRefPubMed Thygesen K, Alpert JS, Jaffe AS, Simoons ML, Chaitman BR, White HD, Thygesen K, Alpert JS, White HD, Jaffe AS, Katus HA, Apple FS, Lindahl B, Morrow DA, Chaitman BA, Clemmensen PM, Johanson P, Hod H, Underwood R, Bax JJ, Bonow RO, Pinto F, Gibbons RJ, Fox KA, Atar D, Newby LK, Galvani M, Hamm CW, Uretsky BF, Steg PG, Wijns W, Bassand JP, Menasche P, Ravkilde J, Ohman EM, Antman EM, Wallentin LC, Armstrong PW, Simoons ML, Januzzi JL, Nieminen MS, Gheorghiade M, Filippatos G, Luepker RV, Fortmann SP, Rosamond WD, Levy D, Wood D, Smith SC, Hu D, Lopez-Sendon JL, Robertson RM, Weaver D, Tendera M, Bove AA, Parkhomenko AN, Vasilieva EJ, Mendis S (2012) Third universal definition of myocardial infarction. Eur Heart J 33(20):2551–2567CrossRefPubMed
27.
go back to reference Dindo D, Demartines N, Clavien P-A (2004) Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg 240(2):205–213CrossRefPubMedPubMedCentral Dindo D, Demartines N, Clavien P-A (2004) Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg 240(2):205–213CrossRefPubMedPubMedCentral
28.
go back to reference Slankamenac K, Graf R, Barkun J, Puhan MA, Clavien PA (2013) The comprehensive complication index: a novel continuous scale to measure surgical morbidity. Ann Surg 258(1):1–7CrossRefPubMed Slankamenac K, Graf R, Barkun J, Puhan MA, Clavien PA (2013) The comprehensive complication index: a novel continuous scale to measure surgical morbidity. Ann Surg 258(1):1–7CrossRefPubMed
29.
go back to reference Lerut T, Coosemans W, Decker G, De Leyn P, Nafteux P, van Raemdonck D (2002) Anastomotic complications after esophagectomy. Dig Surg 19(2):92–98CrossRefPubMed Lerut T, Coosemans W, Decker G, De Leyn P, Nafteux P, van Raemdonck D (2002) Anastomotic complications after esophagectomy. Dig Surg 19(2):92–98CrossRefPubMed
30.
go back to reference Suma H, Takanashi R (1990) Arteriosclerosis of the gastroepiploic and internal thoracic arteries. Ann Thorac Surg 50(3):413–416CrossRefPubMed Suma H, Takanashi R (1990) Arteriosclerosis of the gastroepiploic and internal thoracic arteries. Ann Thorac Surg 50(3):413–416CrossRefPubMed
31.
go back to reference Salo JA, Perhoniemi VJ, Heikkinen LO, Verkkala KA, Jarvinen AA (1992) Pulse oximetry for the assessment of gastric tube circulation in esophageal replacements. Am J Surg 163(4):446–447CrossRefPubMed Salo JA, Perhoniemi VJ, Heikkinen LO, Verkkala KA, Jarvinen AA (1992) Pulse oximetry for the assessment of gastric tube circulation in esophageal replacements. Am J Surg 163(4):446–447CrossRefPubMed
32.
go back to reference Pierie JP, De Graaf PW, Poen H, Van der Tweel I, Obertop H (1994) Impaired healing of cervical esophagogastrostomies can be predicted by estimation of gastric serosal blood perfusion by laser Doppler flowmetry. Eur J Surg 160(11):599–603PubMed Pierie JP, De Graaf PW, Poen H, Van der Tweel I, Obertop H (1994) Impaired healing of cervical esophagogastrostomies can be predicted by estimation of gastric serosal blood perfusion by laser Doppler flowmetry. Eur J Surg 160(11):599–603PubMed
33.
go back to reference Kulik A, Ruel M (2011) Lipid-lowering therapy and coronary artery bypass graft surgery: what are the benefits? Curr Opin Cardiol 26(6):508–517CrossRefPubMed Kulik A, Ruel M (2011) Lipid-lowering therapy and coronary artery bypass graft surgery: what are the benefits? Curr Opin Cardiol 26(6):508–517CrossRefPubMed
34.
go back to reference Deo SV, Dunlay SM, Shah IK, Altarabsheh SE, Erwin PJ, Boilson BA, Park SJ, Joyce LD (2013) Dual anti-platelet therapy after coronary artery bypass grafting: is there any benefit? A systematic review and meta-analysis. J Card Surg 28(2):109–116CrossRefPubMed Deo SV, Dunlay SM, Shah IK, Altarabsheh SE, Erwin PJ, Boilson BA, Park SJ, Joyce LD (2013) Dual anti-platelet therapy after coronary artery bypass grafting: is there any benefit? A systematic review and meta-analysis. J Card Surg 28(2):109–116CrossRefPubMed
35.
go back to reference Bedenis R, Lethaby A, Maxwell H, Acosta S, Prins MH (2015) Antiplatelet agents for preventing thrombosis after peripheral arterial bypass surgery. Cochrane Database Syst Rev 2:CD000535 Bedenis R, Lethaby A, Maxwell H, Acosta S, Prins MH (2015) Antiplatelet agents for preventing thrombosis after peripheral arterial bypass surgery. Cochrane Database Syst Rev 2:CD000535
36.
go back to reference Antiplatelet Trialists’ Collaboration (1994) Collaborative overview of randomised trials of antiplatelet therapy–II: maintenance of vascular graft or arterial patency by antiplatelet therapy. BMJ 308(6922):159–168CrossRef Antiplatelet Trialists’ Collaboration (1994) Collaborative overview of randomised trials of antiplatelet therapy–II: maintenance of vascular graft or arterial patency by antiplatelet therapy. BMJ 308(6922):159–168CrossRef
37.
go back to reference Higgins DF, Kimura K, Iwano M, Haase VH (2008) Hypoxia-inducible factor signaling in the development of tissue fibrosis. Cell Cycle (Georgetown, Tex) 7(9):1128–1132CrossRef Higgins DF, Kimura K, Iwano M, Haase VH (2008) Hypoxia-inducible factor signaling in the development of tissue fibrosis. Cell Cycle (Georgetown, Tex) 7(9):1128–1132CrossRef
38.
go back to reference Scholz CC, Cavadas MA, Tambuwala MM, Hams E, Rodriguez J, von Kriegsheim A, Cotter P, Bruning U, Fallon PG, Cheong A, Cummins EP, Taylor CT (2013) Regulation of IL-1beta-induced NF-kappaB by hydroxylases links key hypoxic and inflammatory signaling pathways. Proc Natl Acad Sci USA 110(46):18490–18495CrossRefPubMedPubMedCentral Scholz CC, Cavadas MA, Tambuwala MM, Hams E, Rodriguez J, von Kriegsheim A, Cotter P, Bruning U, Fallon PG, Cheong A, Cummins EP, Taylor CT (2013) Regulation of IL-1beta-induced NF-kappaB by hydroxylases links key hypoxic and inflammatory signaling pathways. Proc Natl Acad Sci USA 110(46):18490–18495CrossRefPubMedPubMedCentral
40.
go back to reference Han WQ, Zhu Q, Hu J, Li PL, Zhang F, Li N (2013) Hypoxia-inducible factor prolyl-hydroxylase-2 mediates transforming growth factor beta 1-induced epithelial-mesenchymal transition in renal tubular cells. Biochim Biophys Acta 1833(6):1454–1462CrossRefPubMedPubMedCentral Han WQ, Zhu Q, Hu J, Li PL, Zhang F, Li N (2013) Hypoxia-inducible factor prolyl-hydroxylase-2 mediates transforming growth factor beta 1-induced epithelial-mesenchymal transition in renal tubular cells. Biochim Biophys Acta 1833(6):1454–1462CrossRefPubMedPubMedCentral
41.
go back to reference Nolan KA, Brennan EP, Scholz CC, Cullen C, Ryan A, Taylor CT, Godson C (2015) Paricalcitol protects against TGF-beta1-induced fibrotic responses in hypoxia and stabilises HIF-alpha in renal epithelia. Exp Cell Res 330(2):371–381CrossRefPubMed Nolan KA, Brennan EP, Scholz CC, Cullen C, Ryan A, Taylor CT, Godson C (2015) Paricalcitol protects against TGF-beta1-induced fibrotic responses in hypoxia and stabilises HIF-alpha in renal epithelia. Exp Cell Res 330(2):371–381CrossRefPubMed
42.
go back to reference Kelley ST, Coppola D, Karl RC (2004) Neoadjuvant chemoradiotherapy is not associated with a higher complication rate vs. surgery alone in patients undergoing esophagectomy. J Gastrointest Surg 8(3):227–231 (discussion 231–222) CrossRefPubMed Kelley ST, Coppola D, Karl RC (2004) Neoadjuvant chemoradiotherapy is not associated with a higher complication rate vs. surgery alone in patients undergoing esophagectomy. J Gastrointest Surg 8(3):227–231 (discussion 231–222) CrossRefPubMed
43.
go back to reference Zhou D, Liu QX, Deng XF, Min JX, Dai JG (2015) Comparison of two different mechanical esophagogastric anastomosis in esophageal cancer patients: a meta-analysis. J Cardiothorac Surg 10:67CrossRefPubMedPubMedCentral Zhou D, Liu QX, Deng XF, Min JX, Dai JG (2015) Comparison of two different mechanical esophagogastric anastomosis in esophageal cancer patients: a meta-analysis. J Cardiothorac Surg 10:67CrossRefPubMedPubMedCentral
44.
go back to reference Honda M, Kuriyama A, Noma H, Nunobe S, Furukawa TA (2013) Hand-sewn versus mechanical esophagogastric anastomosis after esophagectomy: a systematic review and meta-analysis. Ann Surg 257(2):238–248CrossRefPubMed Honda M, Kuriyama A, Noma H, Nunobe S, Furukawa TA (2013) Hand-sewn versus mechanical esophagogastric anastomosis after esophagectomy: a systematic review and meta-analysis. Ann Surg 257(2):238–248CrossRefPubMed
45.
go back to reference Deng XF, Liu QX, Zhou D, Min JX, Dai JG (2015) Hand-sewn vs linearly stapled esophagogastric anastomosis for esophageal cancer: a meta-analysis. World J Gastroenterol 21(15):4757–4764PubMedPubMedCentral Deng XF, Liu QX, Zhou D, Min JX, Dai JG (2015) Hand-sewn vs linearly stapled esophagogastric anastomosis for esophageal cancer: a meta-analysis. World J Gastroenterol 21(15):4757–4764PubMedPubMedCentral
46.
go back to reference Ercan S, Rice TW, Murthy SC, Rybicki LA, Blackstone EH (2005) Does esophagogastric anastomotic technique influence the outcome of patients with esophageal cancer? J Thorac Cardiovasc Surg 129(3):623–631CrossRefPubMed Ercan S, Rice TW, Murthy SC, Rybicki LA, Blackstone EH (2005) Does esophagogastric anastomotic technique influence the outcome of patients with esophageal cancer? J Thorac Cardiovasc Surg 129(3):623–631CrossRefPubMed
47.
go back to reference Nederlof N, Tilanus HW, Tran TC, Hop WC, Wijnhoven BP, de Jonge J (2011) End-to-end versus end-to-side esophagogastrostomy after esophageal cancer resection: a prospective randomized study. Ann Surg 254(2):226–233CrossRefPubMed Nederlof N, Tilanus HW, Tran TC, Hop WC, Wijnhoven BP, de Jonge J (2011) End-to-end versus end-to-side esophagogastrostomy after esophageal cancer resection: a prospective randomized study. Ann Surg 254(2):226–233CrossRefPubMed
48.
go back to reference Yuan Y, Zeng X, Hu Y, Xie T, Zhao Y (2014) Omentoplasty for esophagogastrostomy after esophagectomy. Cochrane Database Syst Rev 10:CD008446 Yuan Y, Zeng X, Hu Y, Xie T, Zhao Y (2014) Omentoplasty for esophagogastrostomy after esophagectomy. Cochrane Database Syst Rev 10:CD008446
49.
go back to reference Markar SR, Arya S, Karthikesalingam A, Hanna GB (2013) Technical factors that affect anastomotic integrity following esophagectomy: systematic review and meta-analysis. Ann Surg Oncol 20(13):4274–4281CrossRefPubMed Markar SR, Arya S, Karthikesalingam A, Hanna GB (2013) Technical factors that affect anastomotic integrity following esophagectomy: systematic review and meta-analysis. Ann Surg Oncol 20(13):4274–4281CrossRefPubMed
50.
go back to reference Page RD, Asmat A, McShane J, Russell GN, Pennefather SH (2013) Routine endoscopy to detect anastomotic leakage after esophagectomy. Ann Thorac Surg 95(1):292–298CrossRefPubMed Page RD, Asmat A, McShane J, Russell GN, Pennefather SH (2013) Routine endoscopy to detect anastomotic leakage after esophagectomy. Ann Thorac Surg 95(1):292–298CrossRefPubMed
51.
go back to reference Schaible A, Sauer P, Hartwig W, Hackert T, Hinz U, Radeleff B, Büchler MW, Werner J (2014) Radiologic versus endoscopic evaluation of the conduit after esophageal resection: a prospective, blinded, intraindividually controlled diagnostic study. Surg Endosc 28(7):2078–2085CrossRefPubMed Schaible A, Sauer P, Hartwig W, Hackert T, Hinz U, Radeleff B, Büchler MW, Werner J (2014) Radiologic versus endoscopic evaluation of the conduit after esophageal resection: a prospective, blinded, intraindividually controlled diagnostic study. Surg Endosc 28(7):2078–2085CrossRefPubMed
Metadata
Title
Risk Factors for Anastomotic Stricture Post-esophagectomy with a Standardized Sutured Anastomosis
Authors
Zuhair Ahmed
Jessie A. Elliott
Sinead King
Claire L. Donohoe
Narayanasamy Ravi
John V. Reynolds
Publication date
01-02-2017
Publisher
Springer International Publishing
Published in
World Journal of Surgery / Issue 2/2017
Print ISSN: 0364-2313
Electronic ISSN: 1432-2323
DOI
https://doi.org/10.1007/s00268-016-3746-0

Other articles of this Issue 2/2017

World Journal of Surgery 2/2017 Go to the issue